My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > EPZ011989

EPZ011989

Catalog No. Product Name Size List Price (US$) Quantity
APIM050326 EPZ011989 10 mg 80.00
APIM050326 EPZ011989 50 mg 180.00
APIM050326 EPZ011989 100 mg 280.00
APIM050326 EPZ011989 200 mg 480.00
Description

Background Information:

EPZ011989 is a cell permeable, metabolically stable and orally available EZH2 inhibitor, a compound with oral exposure and metabolic stability that is able to elicit robust methyl mark inhibition and antitumor activity. It binds potently and selectively to the mutant and wild-type EZH2 with Ki values < 3 nM, and highly selective over closely-related EZH1 (>15-fold selectivity) and 20 other histone methyltransferases (HMTs) (>3000-fold selectivity) tested. Demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. Reduces cellular H3K27 methylation in the Y641F, mutant-bearing human lymphoma cell line, WSU-DLCL2, with IC50s below 100 nM.

Reference:

1. J. E. Campbell, et al, EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity, ACS Med Chem Lett. 2015 Mar 4;6 (5):491-495*Clean and impeccable product, made for reproducible high quality research.

APIM050326: EPZ011989

CAS No.: 1598383-40-4.
Molecular Formula: C35H51N5O4 ?HCl ? H2O.
Molecular Weight: 660.3.
Purity: >99.5% purity (HPLC at 214 and 254 nm).
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis Report.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

Related Links

See our Privacy Policy